Safety and Efficacy of the Soluble Guanylate Cyclase Stimulator Praliciguat in Patients with Heart Failure with Preserved Ejection Fraction (Capacity HFpEF): A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2 Trial

被引：0
|
作者：
Udelson, James E. [1 ]
Lewis, Gregory D. [2 ]
Shah, Sanjiv J. [3 ]
Zile, Michael R. [4 ,5 ]
Redfield, Margaret M. [6 ]
Burnett, John [6 ]
Parker, John D. [7 ]
Seferovic, Jelena [8 ]
Wilson, Phebe J. [8 ]
Mittleman, Robert S. [9 ]
Profy, Albert T. [8 ]
Konstam, Marvin A. [1 ]
机构：
[1] Tufts Med Ctr, Boston, MA 02111 USA
[2] Harvard Med Sch, Massachusetts Gen Hosp, Boston, MA 02115 USA
[3] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA
[4] Med Univ South Carolina, Charleston, SC 29425 USA
[5] RHJ Dept VA Med Ctr, Charleston, SC USA
[6] Mayo Clin, Rochester, MN USA
[7] Univ Hlth Network, Mt Sinai Hosp, Toronto, ON, Canada
[8] Cycler Therapeut, Boston, MA USA
[9] Ironwood Pharmaceut, Cambridge, MA USA
来源：
JOURNAL OF CARDIAC FAILURE | 2020年 / 26卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
014
引用
收藏
页码：S8 / S8
页数：1
相关论文
共 50 条
  • [31] The effects of qishen granules for patients with chronic heart failure: A multicenter randomized double-blind placebo-controlled trial
    Du, Kangjia
    Liu, Junjie
    Tan, Nannan
    Huang, Xinyi
    Wang, Juan
    Zhao, Huihui
    Wang, Wei
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [32] An exploratory, randomised, placebo-controlled, 14 day trial of the soluble guanylate cyclase stimulator praliciguat in participants with type 2 diabetes and hypertension
    Hanrahan, John P.
    Seferovic, Jelena P.
    Wakefield, James D.
    Wilson, Phebe J.
    Chickering, Jennifer G.
    Jung, Joon
    Carlson, Kenneth E.
    Zimmer, Daniel P.
    Frelinger, Andrew L., III
    Michelson, Alan D.
    Morrow, Linda
    Hall, Michael
    Currie, Mark G.
    Milne, G. Todd
    Profy, Albert T.
    DIABETOLOGIA, 2020, 63 (04) : 733 - 743
  • [33] Efficacy of Xinbao pill on chronic heart failure: Study protocol of a multicenter, randomized, double-blind, placebo-controlled trial
    Wang, Yuanping
    Li, Jiahua
    Yan, Jiaqi
    Wang, Yulin
    Cheng, Yuanyuan
    Liu, Zhongqiu
    Wang, Dawei
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [34] Elderly, postmenopausal females with heart failure with preserved ejection fraction (HFpEF) are responsive to soluble guanylate cyclase (sGC) stimulation: a post hoc analysis of the CAPACITY trial
    Busch, Andreas
    Wilson, Phebe
    Milne, G. Todd
    Profi, Albert T.
    JOURNAL OF TRANSLATIONAL MEDICINE, 2023, 21 (SUPPL 1)
  • [35] Elderly, postmenopausal females with heart failure with preserved ejection fraction (HFpEF) are responsive to soluble guanylate cyclase (sGC) stimulation: a post hoc analysis of the CAPACITY trial
    Busch, Andreas
    Wilson, Phebe
    Milne, G. Todd
    Profi, Albert T.
    JOURNAL OF TRANSLATIONAL MEDICINE, 2023, 21
  • [36] Vascular Effects of Eplerenone in Coronary Artery Disease With Preserved Ejection Fraction: A Double-Blind, Randomized, Placebo-Controlled Trial
    Sudano, Isabella
    Naegele, Matthias
    Roas, Susanne
    Periat, Daniel
    Frank, Michelle
    Kouroedov, Alexey
    Noll, Georg
    Luscher, Thomas F.
    Enseleit, Frank
    Ruschitzka, Frank
    Flammer, Andreas J.
    CLINICAL CARDIOLOGY, 2016, 39 (05) : 285 - 290
  • [37] Safety and efficacy of the partial adenosine A1 receptor agonist neladenoson bialanate in patients with chronic heart failure with reduced ejection fraction: a phase IIb, randomized, double-blind, placebo-controlled trial
    Voors, Adriaan A.
    Bax, Jeroen J.
    Hernandez, Adrian F.
    Wirtz, Antonieta B.
    Pap, Akos F.
    Ferreira, Anna C.
    Senni, Michele
    van der Laan, Michael
    Butler, Javed
    EUROPEAN JOURNAL OF HEART FAILURE, 2019, 21 (11) : 1426 - 1433
  • [38] Patient-reported outcomes in the SOluble guanylate Cyclase stimulatoR in heArT failurE patientS with PRESERVED ejection fraction (SOCRATES-PRESERVED) study
    Filippatos, Gerasimos
    Maggioni, Aldo P.
    Lam, Carolyn S. P.
    Pieske-Kraigher, Elisabeth
    Butler, Javed
    Spertus, John
    Ponikowski, Piotr
    Shah, Sanjiv J.
    Solomon, Scott D.
    Scalise, Andrea-Viviana
    Mueller, Katharina
    Roessig, Lothar
    Bamber, Luke
    Gheorghiade, Mihai
    Pieske, Burkert
    EUROPEAN JOURNAL OF HEART FAILURE, 2017, 19 (06) : 782 - 791
  • [39] Randomized double-blind placebocontrolled trial of perhexiline in heart failure with preserved ejection fraction syndrome
    Singh, Satnam
    Beadle, Roger
    Cameron, Donnie
    Rudd, Amelia
    Bruce, Maggie
    Jagpal, Baljit
    Schwarz, Konstantin
    Brindley, Gemma
    Mckiddie, Fergus
    Lang, Chim
    Dawson, Dana
    Frenneaux, Michael
    FUTURE CARDIOLOGY, 2014, 10 (06) : 693 - 698
  • [40] Efficacy and safety of oral tolvaptan in patients undergoing hemodialysis: a Phase 2, double-blind, randomized, placebo-controlled trial
    Ogata, Hiroaki
    Shimofurutani, Naoko
    Okada, Tadashi
    Nagamoto, Hisashi
    Akizawa, Tadao
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2021, 36 (06) : 1088 - 1097
12345